# The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain

> **NCT06614608** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiangsu Aosaikang Pharmaceutical Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Osteoarthritis, Knee
- Pain

## Interventions

- **DRUG:** 5% ASKC200
- **DRUG:** 1% ASKC200

## Key facts

- **NCT ID:** NCT06614608
- **Lead sponsor:** Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2025-04
- **Final completion:** 2025-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614608, "The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06614608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*